Camlin Fine Sciences' Q3 FY 2025-26 Quarterly Results
- 14 Feb 2026
Result Summary
- Camlin Fine Sciences Ltd reported a 0.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 5.8%.
- Its expenses for the quarter were up by 1.3% QoQ and 8.5% YoY.
- The net profit increased 148.2% QoQ and increased 396.0% YoY.
- The earnings per share (EPS) of Camlin Fine Sciences Ltd declined at 1.91 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 460.13 | 464.42 | 434.83 | -0.9% | 5.8% |
Total Expenses | 470.22 | 464.15 | 433.30 | 1.3% | 8.5% |
Profit Before Tax | -27.60 | 0.27 | 1.52 | -10322.2% | -1915.8% |
Tax | 0.05 | 5.91 | 7.14 | -99.2% | -99.3% |
Profit After Tax | -37.10 | -14.95 | -7.48 | 148.2% | 396.0% |
Earnings Per Share | -1.91 | -0.75 | -0.24 | 154.7% | 695.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Camlin Fine Sciences Ltd is a company primarily operating in the chemical industry, known for manufacturing specialty chemicals and ingredients. The company specializes in producing antioxidants, aroma chemicals, and performance chemicals. These products serve various industries, including food, animal nutrition, and pharmaceuticals. As of the last update, no specific major developments or changes were reported for the company. Camlin Fine Sciences is recognized for its global presence and commitment to quality and sustainability in its manufacturing processes.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Camlin Fine Sciences Ltd reported a total income of ₹460.13 crores. This marks a slight decrease of 0.9% compared to the previous quarter (Q2FY26), where the total income was ₹464.42 crores. However, there is an increase in total income by 5.8% when compared to the same quarter in the previous year (Q3FY25), which recorded ₹434.83 crores. This year-over-year growth indicates a modest increase in revenue generation over the past year, reflecting changes in the company's operational scale or market demand for its products.
Profitability
The profitability metrics for Camlin Fine Sciences Ltd in Q3FY26 indicate a challenging quarter. The company reported a loss before tax of ₹27.60 crores, a significant decline from the minimal profit of ₹0.27 crores in Q2FY26 and ₹1.52 crores in Q3FY25. The tax expense decreased drastically to ₹0.05 crores in Q3FY26 from ₹5.91 crores in the previous quarter and ₹7.14 crores in the same quarter last year. Consequently, the profit after tax (PAT) stood at a loss of ₹37.10 crores, representing a 148.2% increase in losses quarter-over-quarter and a 396.0% increase year-over-year. Earnings per share (EPS) also reflected this trend, with a decrease to -₹1.91 in Q3FY26 from -₹0.75 in Q2FY26 and -₹0.24 in Q3FY25.
Operating Metrics
The total expenses for Camlin Fine Sciences Ltd in Q3FY26 amounted to ₹470.22 crores, showing a 1.3% increase from ₹464.15 crores in the previous quarter. Year-over-year, total expenses increased by 8.5% from ₹433.30 crores in Q3FY25. These figures highlight a rise in operational costs over both the quarter and the year. The company's earnings per share also saw considerable changes, decreasing to -₹1.91 in Q3FY26, reflecting a 154.7% decline from Q2FY26 and a 695.8% decline from Q3FY25. These operating metrics indicate a period of increased financial pressure, marked by rising expenses and declining earnings.